Bireta Christian, Tirilomis Theodor, Grossmann Marius, Unsöld Bernhard, Wachter Rolf, Perl Thorsten, Jebran Ahmad Fawad, Schoendube Friedrich Albert, Popov Aron Frederik
J Cardiothorac Surg. 2015 Jan 31;10:14. doi: 10.1186/s13019-015-0218-9.
Giant-cell myocarditis (GCM) is known as a rare, rapidly progressive, and frequently fatal myocardial disease in young and middle-aged adults. We report about a 76 year old male patient who underwent implantation with a biventricular Berlin Heart Excor system at the age of 74 due to acute biventricular heart failure caused by giant-cell myocarditis. The implantation was without any surgical problems; however, a difficulty was the immunosuppressive therapy after implantation. Meanwhile the patient is 76 years old and lives with circulatory support for about 3 years without major adverse events. Also, in terms of mobility in old age there are no major limitations. It seems that in even selected elderly patients an implantation of a long term support with the biventricular Berlin Heart Excor is a useful therapeutic option with an acceptable outcome.
巨细胞性心肌炎(GCM)是一种罕见的、进展迅速且常导致中青年患者死亡的心肌疾病。我们报告了一名76岁男性患者,他在74岁时因巨细胞性心肌炎导致急性双心室心力衰竭,接受了双心室柏林心脏体外循环系统植入手术。植入过程没有任何手术问题;然而,术后免疫抑制治疗是一个难题。该患者目前76岁,依靠循环支持存活了约3年,没有发生重大不良事件。而且,在老年患者的活动能力方面也没有重大限制。看来,即使是特定的老年患者,植入双心室柏林心脏体外循环系统进行长期支持也是一种有效的治疗选择,且预后可以接受。